Moderna completed enrollment of phase 3 COVE study of mRNA vaccine against COVID-19
On Oct. 22, 2020, Moderna announced that it had completed enrollment of 30,000 participants for the Phase 3…
-
-
Todos Medical announced distribution agreement with Adial Pharma to market Assure/FaStep Covid-19 antibody tests
On Oct. 22, 2020, Todos Medical and Adial Pharmaceuticals announced that the companies have entered into a distribution agreement…
-
Biotechnology | COVID-19 | FDA | Therapeutics
FDA approved Gilead’s antiviral Veklury (remdesivir) for treatment of COVID-19
On Oct. 22, 2020, Gilead Sciences announced that the FDA had approved the antiviral drug Veklury (remdesivir) for…
-
Landmark TB trial identified shorter-course treatment regimen
On Oct. 21, 2020, results from an international, randomized, controlled clinical trial indicated that a four-month daily treatment…
-
ViiV Healthcare analysis showed no antiretroviral therapy interruptions due to COVID-19
On Oct. 21, 2020, ViiV Healthcare, majority owned by GSK, with Pfizer and Shionogi Limited as shareholders, announced…
-
ImmunityBio, NantKwest announced first patient dosed in phase 1 clinical trial of second-generation COVID-19 vaccine candidate
On Oct. 21, 2020, ImmunityBio and NantKwest announced that the first patient had been dosed in the Phase…
-
CerTest Biotec and BD announced CE Mark for combination COVID-19, Influenza, RSV test
On Oct. 21, 2020, CerTest Biotec, along with BD (Becton, Dickinson), announced that the VIASURE SARS-CoV-2 (N1 +…
-
Evidence review confirmed CDC guidance about infectivity of novel coronavirus
On Oct. 20, 2020, researchers at Oregon Health & Science University (OHSU) and Oregon State University (OSU) reported…
-
Merck announced positive topline results from phase 3 adult studies evaluating V114 15-valent pneumococcal conjugate vaccine
On Oct. 20, 2020, Merck announced findings from two additional Phase 3 studies evaluating the safety, tolerability and…
-
Final report confirmed remdesivir benefits for COVID-19
On Oct. 20, 2020, the National Institutes of Health (NIH) has launched an adaptive Phase 3 clinical trial…
-
PerkinElmer immunoassay identiied therapeutic compounds capable of disrupting the SARS-CoV-2 spike protein/ACE2 interaction
On Oct. 20, 2020, PerkinElmer announced that a research team at the National Center for Advancing Translational Sciences…
-
Agriculture | Artificial Intelligence | Biotechnology | CMO | CRO | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
U.S. Department of Defense approved $87 million for newest bioindustrial manufacturing innovation institute
On Oct. 20, 2020, the U.S. Department of Defense announced an $87 million, seven-year award to the BioIndustrial…
-
OPKO Health’s BioReference Laboratories launched multiplex COVID-19 and influenza A/B test
On Oct. 20, 2020, BioReference Laboratories, an OPKO Health company, announced that it was accepting specimens for a…
-
European Investment Bank provided Immunic with €24.5 million to support development of COVID-19 therapy
On Oct. 20, 2020, the European Investment Bank (EIB) and Immunic announced the signing of a €24.5 million…
-
Alberta Enterprise Corporation invested additional $5 million to benefit Alberta startups
On Oct. 19, 2020, Alberta Enterprise announced that it had invested an additional $5 million into its third…
-
Biotechnology | Genomics | Neurology | NIH
Study discovered gene that helps us know when it’s time to urinate
On Oct. 19, 2020, researchers announced they had discovered that a gene, called PIEZO2, may be responsible for…
-
Mateon’s phase 2 global study for OT-101/ TGF- Inhibitor against COVID-19 cleared for patient enrollment in Argentina
On Oct. 19, 2020, Mateon Therapeutics announced the receipt of approval from Republica Argentina Poder Ejecutivo Nacional, the…
-
Thermo Fisher Scientific increased availability of COVID-19 testing with sample collection kit from Everlywell
On Oct. 19, 2020, Thermo Fisher Scientific announced it had received an expansion of its Emergency Use Authorization…
-
RNA ‘ticker tape’ records gene activity over time
On Oct. 19, 2020, researchers at MIT, Harvard, and the Broad Institute of MIT announced they had developed…
-
Bio-Techne announced commercial release of SARS-CoV-2 multi-antigen serology assay kit for simple western
On Oct. 19, 2020, Bio-Techne announced that ProteinSimple, a Bio-Techne brand, released its SARS-CoV-2 Multi-Antigen Serology Module for…
-
LabCorp and Swedish extended laboratory services relationship providing access to COVID-19 testing and diagnostics
On Oct. 19, 2020, LabCorp and Swedish, the largest nonprofit healthcare system in the Puget Sound region, announced…
-
LabCorp launched quantitative antibody test to assess effectiveness of COVID-19 vaccines in clinical trials
On Oct. 19, 2020, LabCorp announced a test that provided a quantitative measurement of an individual’s SARS-CoV-2 IgG…
-
BARDA reselected ICON as preferred partner to help strengthen U.S. emergency preparedness and response
On Oct. 19, 2020, ICON announced that it had been re-selected by the Biomedical Advanced Research and Development…
-
Just – Evotec Biologics received grant to enable an antibody product for the prevention of COVID-19
On Oct. 19, 2020, Evotec announced that its Seattle-based subsidiary, Just – Evotec Biologics had received a grant…
-
NIH began large clinical trial to test immune modulators for treatment of COVID-19
On Oct. 16, 2020, the National Institutes of Health (NIH) launched an adaptive Phase 3 clinical trial to…
-
BD announce assay for immune assessment of COVID-19 patients available in Europe
On Oct. 16, 2020, BD (Becton, Dickinson) announced the CE mark and European availability of a product for…
-
U.S. DOD awarded $6.98 million to Teel Plastics to increase production of Swabsticks for COVID-19 testing
On Oct. 16, 2020, the U.S. Department of Defense in coordination with the Department of Health and Human…
-
Entos announced spin-off company Aegis Life to support global vaccine commercialization
On Oct. 15, 2020, Entos Pharmaceuticals announces that its San Diego-based spinout company Aegis Life, will pursuing U.S….
-
Solidarity Therapeutics trial produced conclusive evidence on effectiveness of repurposed drugs for COVID-19
On Oct. 15, 2020, the World Health Organization (WHO) announced Interim that results from the Solidarity Therapeutics Trial,…
-
University of Oxford scientists developed extremely rapid diagnostic test for Covid-19
On Oct. 15, 2020, scientists from the University of Oxford’s Department of Physics announced they had developed an…
